Pasithea Therapeutics Announces FDA Acceptance Of IND Application To Evaluate PAS-004 In Advanced Cancer Patients
Pasithea Therapeutics 宣布 FDA 接受 IND 申请,以评估晚期癌症患者 PAS-004
Pasithea Therapeutics Announces FDA Acceptance Of IND Application To Evaluate PAS-004 In Advanced Cancer Patients
Pasithea Therapeutics 宣布 FDA 接受 IND 申请,以评估晚期癌症患者 PAS-004
使用浏览器的分享功能,分享给你的好友吧